Resource utilization and cost saving analysis of subcutaneous versus intravenous trastuzumab in early breast cancer patients

We conducted an economic evaluation of intravenous (IV) vs subcutaneous (SC) trastuzumab for the treatment of patients with early breast cancer (EBC). Data of patients receiving adjuvant IV trastuzumab at our institute in 2014 were used to study three different treatment scenarios: 1) IV trastuzumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Farolfi, Alberto, Silimbani, Paolo, Gallegati, Davide, Petracci, Elisabetta, Schirone, Alessio, Altini, Mattia, Masini, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655288/
https://www.ncbi.nlm.nih.gov/pubmed/29113393
http://dx.doi.org/10.18632/oncotarget.18527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655288/
https://www.ncbi.nlm.nih.gov/pubmed/29113393
http://dx.doi.org/10.18632/oncotarget.18527

Ejemplares similares